Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-29 Sale | 2024-12-03 5:24 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 15,891 | $20.18 | $320,620 | 144,997 (Direct) | View |
| 2024-11-11 Sale | 2024-11-13 4:49 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 4,109 | $20.03 | $82,300 | 160,888 (Direct) | View |
| 2024-11-04 Sale | 2024-11-06 4:36 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 18,219 | $18.62 | $339,281 | 164,997 (Direct) | View |
| 2024-10-16 Sale | 2024-10-18 4:31 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 600 | $18 | $10,800 | 183,216 (Direct) | View |
| 2024-09-06 Sale | 2024-09-10 4:32 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 3,242 | $15.12 | $49,004 | 183,816 (Direct) | View |
| 2024-07-12 Sale | 2024-07-16 4:43 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 1,238 | $18 | $22,284 | 188,814 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 5:26 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 18,980 | $15.16 | $287,695 | 190,052 (Direct) | View |
| 2023-07-10 Sale | 2023-07-12 4:32 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 17,878 | $18.03 | $322,389 | 153,447 (Direct) | View |
| 2023-04-17 Sale | 2023-04-19 6:06 pm | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 3,961 | $18 | $71,316 | 171,325 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-03 Tax Withholding | 2025-03-04 4:58 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 6,138 | $11.68 | 290,459 (Direct) | View |
| 2025-03-01 Option Award | 2025-03-04 4:58 pm | N/A 2035-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan President, Research & Develop. | 151,600 | $0 | 290,459 (Direct) | View |
| 2024-09-05 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 167 | $15.13 | 187,058 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 151 | $16.93 | 187,058 (Direct) | View |
| 2024-09-04 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 955 | $15.42 | 187,058 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 14 | $17.7 | 187,058 (Direct) | View |
| 2024-09-03 Tax Withholding | 2024-09-05 6:47 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 469 | $15.76 | 187,058 (Direct) | View |
| 2024-03-05 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 1,505 | $12.28 | 275,832 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 414 | $13.37 | 275,832 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-05 7:44 pm | N/A 2034-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 110,900 | $0 | 275,832 (Direct) | View |
| 2024-03-04 Tax Withholding | 2024-03-05 7:44 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 347 | $12.42 | 275,832 (Direct) | View |
| 2023-09-01 Option Award | 2023-09-06 5:09 pm | N/A 2033-09-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 35,700 | $0 | 188,698 (Direct) | View |
| 2023-09-05 Tax Withholding | 2023-09-06 5:09 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 449 | $14.46 | 188,698 (Direct) | View |
| 2023-03-01 Option Award(A) | 2023-04-19 5:50 pm | N/A 2033-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 35,700 | $0 | 196,786 (Direct) | View |
| 2023-03-01 Option Award | 2023-03-03 4:36 pm | N/A 2033-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 71,400 | $0 | 232,486 (Direct) | View |
| 2023-03-02 Tax Withholding | 2023-03-03 4:36 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 1,058 | $11.6 | 232,486 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:33 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 5,794 | $0 | 162,144 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:16 pm | N/A 2032-07-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 34,763 | $0 | 34,763 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:10 pm | N/A 2032-03-01 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 81,113 | $0 | 225,875 (Direct) | View |
| 2021-10-28 Option Award | 2021-11-01 7:02 pm | N/A 2031-10-28 | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 243,639 | $0 | 243,639 (Direct) | View |
Ownership | 2021-10-28 9:01 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Sethuraman Natarajan Chief Scientific Officer | 0 | $0 | 323,881 (Direct) | View |